|Year : 2015 | Volume
| Issue : 4 | Page : 215-226
Review complementary and integrative interventions for cancer-related cognitive changes
Jamie S Myers
School of Nursing, University of Pittsburgh, Pittsburgh, PA; School of Nursing, University of Kansas, Kansas City, KS, USA
|Date of Submission||28-Jun-2015|
|Date of Acceptance||22-Jun-2015|
|Date of Web Publication||30-Nov-2015|
Jamie S Myers
School of Nursing, University of Pittsburgh, Pittsburgh, PA; School of Nursing, University of Kansas, Kansas City, KS
Source of Support: None, Conflict of Interest: None
Cognitive sequelae from a diagnosis of cancer and the subsequent treatment impact survivors' quality of life and can interfere with both social relationships and employment. The search for evidence-based prevention and intervention strategies continues for both central nervous system (CNS) and non-CNS cancer-related cognitive changes. Complementary therapies in conjunction with conventional medicine are being included in integrative programs designed to maximize symptom management in cancer treatment centers providing survivorship care. The purpose of this article is to review the existing evidence for the use of complementary and integrative interventions to prevent or treat cancer-related cognitive changes and to discuss the rationale for current and future research. Search terminology included: Complementary, alternative, and integrative medicine, cognition, cognitive function, and cancer, and yielded 20 studies that met criteria for inclusion. Preliminary results published to date indicate that some complementary therapies may be beneficial to cancer survivors experiencing cognitive concerns. A number of gaps in the literature remain primarily due to preliminary study designs, small sample sizes, lack of objective cognitive testing, and cognitive function not being a primary endpoint for much of the published work.
Keywords: Cancer, cognition, cognitive function, complementary, integrative, interventions
|How to cite this article:|
Myers JS. Review complementary and integrative interventions for cancer-related cognitive changes. Asia Pac J Oncol Nurs 2015;2:215-26
|How to cite this URL:|
Myers JS. Review complementary and integrative interventions for cancer-related cognitive changes. Asia Pac J Oncol Nurs [serial online] 2015 [cited 2016 Dec 5];2:215-26. Available from: http://www.apjon.org/text.asp?2015/2/4/215/162825
| Introduction|| |
Cognitive sequelae from a diagnosis of cancer and the subsequent treatment have a significant impact on survivors' quality of life and can interfere with both social relationships and employment. ,, Primary and secondary tumors of the central nervous system (CNS) long have been recognized to cause impairment in cognitive function due to both direct injury to the CNS by tumor invasion as well as from injury caused by surgery, radiation therapy, and chemotherapy.  More recently, cognitive sequelae from non-CNS malignancies have been recognized and may persist as long as 20 years in a subset of individuals. ,, For these survivors, the level of severity and duration varies, but in many studies has been shown to be mild with only a subset of survivors having prolonged difficulties.  Objective neuropsychological testing indicates difficulties across a number of domains, most frequently including executive function, attention and concentration, short-term memory, and processing speed.  Survivors complain of difficulties with multi-tasking, word-finding, remembering appointments, misplacing items, reading comprehension, and aspects of driving and directions. ,
A number of causal mechanisms for non-CNS cognitive sequelae have been postulated including: Inflammatory cytokine release, impairment of DNA repair mechanisms, genetic predisposition, chemotherapy-induced anemia and/or estrogen suppression, telomere shortening, cell senescence, alteration in the blood-brain barrier, and neural progenitor cell injury. ,,,, Many of these proposed mechanisms are consistent with a model of accelerated aging. , Confounding factors may include the impact of the cancer diagnosis on mood states (anxiety and depression) and the ability to direct attention.  Fatigue, sleep disturbance, and neuropathy also may be related to cognitive complaints. , Research to identify risk factors that may predispose some individuals to more severe and long-lasting complaints is on-going. The search for evidence-based prevention and intervention strategies continues for both CNS and non-CNS cancer-related cognitive changes. A number of pharmacologic and nonpharmacologic interventions have been studied. , Due to mixed study results and variation in study design, a standard of care for prevention or treatment of cognitive sequelae has not been established.  However, the National Comprehensive Cancer Network guidelines recommend regular exercise as one strategy to mitigate the cognitive impact of cancer and cancer therapy. 
In recent years, the investigation of complementary therapies in the United States has been supported by the development of the National Center for Complementary and Integrative Health (NCCIH), an organization within the National Institutes of Health. Complementary therapy is defined by the NCCIH as a "nonmainstream practice used together with conventional medicine" as opposed to alternative medicine which is used "in place of conventional medicine."  Complementary therapies in conjunction with conventional medicine are being included in integrative programs designed to maximize symptom management in cancer treatment centers providing survivorship care. The use of complementary therapies has been demonstrated to be acceptable to individuals with cancer. Results of a recent survey of 1471 cancer survivors indicated that 66.5% reported use of complementary and alternative medicine, 43.3% of whom report use within the past year.  To date, preliminary work has been done to explore the use of various complementary or integrative approaches to cognitive sequelae for cancer survivors. The purpose of this article is to review the existing evidence for the use of complementary and integrative interventions to prevent or treat cancer-related cognitive changes and to discuss the rationale for current and future research.
| Methods|| |
PubMed and CINAHL databases were searched using the following terminology: Complementary, alternative, and integrative medicine, cognition, cognitive function, and cancer. Due to the limited amount of published data in this area of research, criteria for inclusion in this review were articles in which outcomes of perceived cognitive function and/or objective cognitive performance were planned or reported for interventional research conducted with cancer survivors. Articles were included regardless of study design or limitations in an effort to identify all complementary intervention research conducted to date. This search yielded 11 studies ,,,,,,,,, (10 completed and 1 planned) and 4 review articles. ,,, The review articles were utilized to identify two studies not found using the search terminology. , Six additional studies ,,,,, were identified from the recent Oncology Nursing Society Putting Evidence into Practice initiative  and one study was added due to awareness of current literature related to exercise as a potential intervention. ,
| Results|| |
Complementary and integrative therapy research for cancer-related cognitive changes conducted to date includes the investigation of a variety of diverse interventions. The articles included in this review are summarized in [Table 1] and are organized into categories for nutritional supplements, mindfulness-based interventions such as meditation and physical activity with a mindfulness component, and other interventions such as haptotherapy, neurofeedback, acupuncture, and the use of restorative environments. A brief description of the various interventions and rationale for investigation is provided below.
The use of Ginkgo biloba to treat cognitive changes has been investigated for individuals with brain tumors with cognitive complaints following treatment with radiation  and for the prevention of cognitive dysfunction for women receiving adjuvant therapy for breast cancer.  The rationale for studying G. biloba is based on previous research conducted to investigate the use of the herb for individuals with Alzheimer's disease and dementia. Results have been mixed, but G. biloba is thought to demonstrate antioxidant activity, increase cerebral blood flow, improve glucose utilization, and stimulate hippocampal choline uptake. Attia et al. reported that 24 weeks of therapy with 40 mg of G. biloba 3 times a day was associated with improvements on objective tests of executive function, attention, concentration, and verbal memory for 34 patients treated with radiation therapy for brain tumors.  Attia et al. noted a high drop-out rate for participants in the intervention arm. In contrast, Barton et al. found no significant results for the use of G. biloba 60 mg twice a day during chemotherapy for breast cancer versus placebo (n = 166) for the prevention of cognitive changes.
The anti-oxidant properties of Vitamin E have attracted researchers investigating interventions for cognitive dysfunction resulting from temporal lobe radionecrosis  and for studying the potential for combined effects with the cholinesterase inhibitor, donepezil.  Chan et al. found that 1000 international units of Vitamin E per day for a year improved results of the objective tests for global cognitive functioning, attention, verbal memory, language ability, and cognitive flexibility for patients with nasopharyngeal cancer who developed temporal lobe necrosis as a result of radiation therapy.  Jatoi et al. attempted to study Vitamin E in combination with donepezil as a treatment to prevent cognitive impairment for patients with small cell lung cancer following completion of therapy. However, due to narrow inclusion criteria, they were unable to successfully recruit participants and closed the trial after 15 months and a sample size of nine.
Omega-3 fatty acids
Omega-3 fatty acids (also referred to as n-3 polyunsaturated fatty acids) are purported to reduce the production of inflammatory cytokines. Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are obtained from fish oil and have been investigated as treatment for cognitive impairment. A recent meta-analysis indicated positive results for adults with cognitive impairment without dementia.  One study has been published in which EPA and DHA were evaluated in patients with nonsmall cell lung cancer receiving chemoradiotherapy.  In this small study, the intervention group did report better cognitive function than controls, although cognition was not a primary endpoint for the study and no objective cognitive testing was done.
Mindfulness has been operationally defined by a two-component model.  The first component of the model consists of developing skills to sustain attention (typically by focusing on the breath via meditation techniques) on the current experience and developing flexibility for switching focus to keep attention anchored in the current experience. The second component involves cultivating an orientation of curiosity and acceptance to the current experience. Bishop et al. summarize the definition of mindfulness as "the self-regulation of attention, which involves sustained attention, attention switching, and the inhibition of elaborative processing."  Mindfulness also involves gaining insights into ones' thoughts and feelings in order to adopt a decentered perspective and cope with challenges. 
Rationale for the investigation of meditation and other mindfulness-based techniques is related to evidence linked to the reduction of anxiety, depression, and the stress response as well as enhancing the immune system. ,,, Results of meditation studies conducted in children and adults with attention deficit-hyperactive disorder demonstrated positive results for improving cognitive function and laid the foundation for investigation in the cancer population.  Several mechanisms for improved cognitive function have been proposed, including increased activity in neural circuitry associated with attention; prefrontal, temporal, and parietal cortical thickening; and decreases in stress-induced cortisol levels.  Meditation has been postulated to have neuroprotective effects and may reduce age-related cognitive decline.  Meditation, including foci on breathing regulation and control of thoughts and feelings, is postulated as a type of attentional training exercise and has been explored as an intervention for a number of cancer-related symptoms such as anxiety, depression, and fatigue. ,, Three randomized, controlled trials have been published in which meditation has been investigated as a potential intervention for cognitive complaints following treatment for breast , or other types of cancer.  Only one of these studies was designed with performance on objective tests of cognitive function as a primary outcome.  Milbury et al. found significant improvements for verbal memory, short-term memory, and processing speed following a 6-week intervention of Tibetan sound meditation for a small sample of breast cancer survivors with posttreatment cognitive complaints. Results from the other two studies demonstrated improvements in subjective cognitive function for larger samples following mindfulness-based meditation/stress reduction programs. ,
Mindfulness-based music therapy
Lesiuk recently published results from a small study conducted to assess the impact of 4 weeks of mindfulness-based music therapy for women with breast cancer receiving adjuvant chemotherapy.  Music stimuli was identified as a good alternative source for mindfulness focus versus the more traditional focus on the breath. Participants improved on the objective tests of attention following the intervention. Due to the small sample size and lack of a control group, the conclusions that can be drawn from this study are limited.
As with meditation, several forms of exercise include a mindfulness-based component. Exercise and physical activity are of great interest as potential interventions for cancer-related cognitive complaints due to the proposed mechanism of decreasing markers of inflammation associated with cognitive dysfunction and increasing levels of brain-derived neurotrophic factor and hippocampal volume. ,, Likewise, exercise combined with the potential added benefit of mindfulness may potentiate the benefits of either intervention alone as the two interventions may work through different mechanistic pathways. 
Yoga, Tai Chi, and Qigong share many similarities in that each combines physical movements or postures with breathing techniques and meditation with the goal of improving health and well-being.  Yoga practices originate in India and Tibet. Qigong, of which Tai Chi is one form, originates in China. These mind-body practices have been studied as strategies for stress reduction and symptom management in a number of populations and are sometimes referred to as meditative-movement therapies. 
Results of three studies designed to investigate the potential benefits of yoga for cancer-related cognitive complaints in women with breast cancer have been published to date. ,, These studies include a case series for women taking part in an Iyengar-inspired yoga program, a secondary analysis of a randomized controlled trial of a hatha yoga program following the completion of breast cancer treatment and a randomized controlled trial of an integrated yoga program with a supportive counseling component delivered throughout treatment with radiation therapy. Galantino et al. reported improvement trends for tests of objective cognitive function and no difference in perceived cognitive function following the Iyengar-inspired yoga program.  However, they were unable to recruit to their desired sample size and limited their publication of results to four women. Derry et al. and Vadiraja et al. did not assess objective cognitive function. , Results from both studies demonstrated improvements in subjective cognitive function and a dose-response was noted for the hatha yoga program. Markers of inflammatory cytokine levels did decrease for participants who took part in the hatha yoga program, however an association was not demonstrated with subjective cognitive function.  Cognitive function was not a primary endpoint for the investigation of the integrated yoga program. 
One small study was conducted to evaluate a 10-week Tai Chi course for women with any type of cancer at least 12 months following the completion of all cancer therapy.  Improvements in objective tests of cognitive function were demonstrated 1 month after the intervention. The Yang form of Tai Chi was employed and is considered to be a moderate intensity form of exercise designed not to exceed 50% of participants' oxygen intake. The small sample size and lack of a control group limit the conclusions that can be drawn from these encouraging results.
Oh et al. studied the effects of 10 weeks of Qigong for individuals with any type of cancer exposed to, or receiving, chemotherapy.  Improvement in subjective cognitive function was demonstrated at the completion of the intervention. No association between subjective cognitive function and a marker of inflammation (C-reactive protein) was demonstrated. The study design did not include objective tests of cognitive function.
Haptotherapy is a complementary therapy combining touch, counseling, and talking to achieve relaxation and facilitate getting in touch with one's feelings.  This intervention is based on haptonomy in which thoughts, feelings, and words are combined into what is referred to as psycho-tactile contact.  This form of complementary therapy is practiced primarily in the Netherlands and much of the source material is written in the Dutch language.  One study has been published in English in which haptotherapy was investigated as an intervention for perceived well-being in patients receiving chemotherapy.  The intervention involved five sessions over the course of treatment for a very small sample. Subjective cognitive function improved for the intervention group. The interpretation of results is limited by the lack of randomization and the small sample size. Cognition was not a primary outcome for the study.
Neurofeedback (also referred to as electroencephalographic [EEG] - biofeedback) involves the presentation of real-time feedback to individuals regarding their brain waves as measured by EEG electrodes placed on the scalp. , One type of neurofeedback provides the individual with positive reinforcement when a desired brain wave is produced. Reinforcement may be visual or auditory such as seeing a move or hearing music.  Results from studies in which neurofeedback was associated with improved cognitive function for attentional-deficit hyperactivity disorder and traumatic brain injury provided a framework for investigating neurofeedback in the oncology population. , Proposed mechanisms for neurofeedback include enhancement of neuroplasticity and training of the brain to shift away from pathological brain wave patterns through positive reinforcement not unlike operant conditioning. , Description of a planned neurofeedback trial for children treated for primary brain tumors was published in 2012.  More recently, Alvarez et al. reported results of a 10-week neurofeedback intervention for women with breast cancer between 6 and 60 months of completing chemotherapy who report cognitive impairment. This method of neurofeedback differs from that used by de Ruiter et al. in that rather than providing positive feedback for specific brain waves, the participant's brain is allowed to utilize the feedback (brief interruptions in recorded music) to enable self-organization. , Alvarez et al. noted improvements for all self-reported cognitive measures across all study time points. The participants served as their own controls and the sample size was small.
Acupuncture involves the insertion of wire-thin needles into particular locations (acupoints) along specific meridians (channels in the body that transport energy).  Rationale for the investigation of acupuncture involves neurofunctional modulation of the CNS to increase neuroplasticity after injury and increase cerebellar circulation.  A combination of patient education and acupuncture was investigated for the relief of cancer-related fatigue.  No differences in subjective cognitive function, the secondary endpoint, were demonstrated.
One of the earliest complementary therapies investigated for improving cancer-related cognitive complaints was exposure to a restorative environment (such as spending time in a park or garden, observing wildlife, or participating in activities of the arts such as music or painting). , Cimprich and Ronis postulated that exposure to activities that engage fascination and have restorative properties would decrease or prevent attentional fatigue associated with cancer and cancer therapy. Positive results were published from two studies in which improvements were demonstrated for objective cognitive function following the intervention. ,
| Discussion|| |
The investigation of complementary and integrative therapies as interventions for cancer and cancer-related cognitive changes is a relatively nascent field of research. Cimprich's early work in restorative environments for women receiving surgery for breast cancer dates back to 1993, however her follow-up study was not conducted until 2003 and no further work with this intervention has been published. All other studies included in this review have been published since 2003 and no more than three studies have been published for each intervention. Small sample sizes, heterogeneity of tumor types, and variations in study designs limit the conclusions that can be drawn.
Most of the work (nine studies) has been conducted in the area of mindfulness-based interventions. A number of gaps in the literature remain primarily due to preliminary study designs, small sample sizes, lack of objective cognitive testing, and cognitive function not being a primary endpoint for much of the published work. Of the mindfulness-based studies, five were related to mindfulness-based exercise. Three of these studies were randomized, controlled trials, although one involved secondary analysis for a cognitive endpoint added to a larger trial. The results from these three studies investigating yoga, tai chi, and qigong were positive for self-reported cognitive function. The small tai chi study results also were positive for objective cognitive function. Four studies were designed to investigate the types of meditation (Tibetan sound - 1, mindfulness meditation-based stress reduction - 2, and mindfulness-based music therapy - 1). Although results all were positive, only one study design included cognitive function as a primary outcome and included objective cognitive testing.
To date, the bulk of the research conducted in the area of cancer and cancer treatment-related cognitive changes has been with breast cancer survivors. The studies reviewed here are no exception as 11 of 20 are specific to breast cancer. Of note, two studies were focused on primary brain tumors and three involved survivors of any type of cancer.
Study designs vary as to whether both subjective (self-report) and objective (neuropsychological testing) measures are included. Some have postulated that subjective and objective instruments actually measure different constructs of cognitive function with subjective tests being influenced by mood states such as anxiety and depression. , This hypothesis is supported by the frequent lack of correlation between subjective and objective tests. Survivors' perception of cognitive changes has been documented to precede physiological changes in activation and structural changes assessed by neuroimaging.  Neuropsychological testing requires specialized training and can be time-consuming from both a resource and survivor burden perspective. However, documentation of objective cognitive changes has been considered necessary for verifying impairment and may be required for survivors' seeking medical disability. Recent work by Von Ah et al. indicated that the perceived cognitive abilities subscale of the Functional Assessment Cancer Therapy-cognition may be clinically relevant and useful as an assessment tool in clinical practice outside the constraints of a clinical trial.  Eight of the 20 studies reviewed here were designed to assess both subjective and cognitive functions. The majority (11 studies) included the self-report measures alone.
The sheer volume of available neuropsychological measures complicates comparing results across trials. Recently, the International Cancer and Cognition Task Force published recommendations for core measures to be included in prospective trials.  These measures are specific to the cognitive domains of executive function, memory, and processing speed and are believed to be more appropriate for capturing the subtlety of cognitive changes for this patient population than global cognitive measures. 
| Conclusions and Recommendations for Future Research|| |
The study results published to date indicate that some complementary therapies may be beneficial to cancer survivors experiencing cognitive concerns. Further work is needed to ascertain the mechanisms behind mindfulness-based interventions. However, the preliminary results discussed here indicate some promise in the use of mindfulness-based interventions for cancer and cancer treatment-related cognitive complaints. Larger, randomized controlled trials are needed to establish effect sizes for specific types of mindfulness-based interventions. Comparisons between nonmindfulness-based exercise, mindfulness-based exercise, and meditation would be of interest to ascertain potential differences in mechanisms and efficacy. Likewise, further work is needed to determine the most efficacious timing, duration, and intensity of the interventions. Study populations need to continue to be expanded beyond breast cancer as the phenomenon of cancer and cancer treatment-related cognitive changes is not restricted to breast cancer survivors. Additional prospective trials designed to measure both subjective and objective cognitive functions following complementary and integrative interventions to minimize cognitive changes still are needed to inform evidence-based practice changes.
Financial support and sponsorship
National Institute of Nursing Research (T32TNR011972A).
Conflicts of interest
There are no conflicts of interest.
| References|| |
Boykoff N, Moieni M, Subramanian SK. Confronting chemobrain: An in-depth look at survivors′ reports of impact on work, social networks, and health care response. J Cancer Surviv 2009;3:223-32.
Myers JS. Chemotherapy-related cognitive impairment: The breast cancer experience. Oncol Nurs Forum 2012;39:E31-40.
Von Ah D, Habermann B, Carpenter JS, Schneider BL. Impact of perceived cognitive impairment in breast cancer survivors. Eur J Oncol Nurs 2013;17:236-41.
Bohan EM. Cognitive changes associated with central nervous system malignancies and treatment. Semin Oncol Nurs 2013;29:238-47.
Ahles TA, Root JC, Ryan EL. Cancer- and cancer treatment-associated cognitive change: An update on the state of the science. J Clin Oncol 2012;30:3675-86.
Koppelmans V, Breteler MM, Boogerd W, Seynaeve C, Schagen SB. Late effects of adjuvant chemotherapy for adult onset non-CNS cancer; cognitive impairment, brain structure and risk of dementia. Crit Rev Oncol Hematol 2013;88:87-101.
Koppelmans V, de Groot M, de Ruiter MB, Boogerd W, Seynaeve C, Vernooij MW, et al.
Global and focal white matter integrity in breast cancer survivors 20 years after adjuvant chemotherapy. Hum Brain Mapp 2014;35:889-99.
Ahles TA. Cognitive changes associated with cancer and cancer treatment. Semin Oncol Nurs 2013;29:229-31.
Von Ah D. Cognitive changes associated with cancer and cancer treatment: State of the science. Clin J Oncol Nurs 2015;19:47-56.
Ahles TA, Saykin AJ. Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 2007;7:192-201.
Cleeland CS, Bennett GJ, Dantzer R, Dougherty PM, Dunn AJ, Meyers CA, et al.
Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 2003;97:2919-25.
Dietrich J, Han R, Yang Y, Mayer-Pröschel M, Noble M. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro
and in vivo
. J Biol 2006;5:22.
Jansen C, Miaskowski C, Dodd M, Dowling G, Kramer J. Potential mechanisms for chemotherapy-induced impairments in cognitive function. Oncol Nurs Forum 2005;32:1151-63.
Mandelblatt JS, Hurria A, McDonald BC, Saykin AJ, Stern RA, VanMeter JW, et al.
Cognitive effects of cancer and its treatments at the intersection of aging: What do we know; what do we need to know? Semin Oncol 2013;40:709-25.
Cimprich B, So H, Ronis DL, Trask C. Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer. Psychooncology 2005;14:70-8.
Myers JS. Neuropsychologic testing for chemotherapy-related cognitive impairment. Adv Exp Med Biol 2010;678:55-69.
Von Ah D, Jansen CE, Allen DH. Evidence-based interventions for cancer- and treatment-related cognitive impairment. Clin J Oncol Nurs 2014;18 Suppl:17-25.
Asher A, Myers JS. The effect of cancer treatment on cognitive function. Clin Adv Hematol Oncol 2015;13:441-450.
NCCN Guidelines Survivorship. National Comprehensive Cancer Network; 2015. Available from: http://www.nccn.org/
. [Last updated on 2/27/15; Last accessed on 2015 Apr 01].
Mao JJ, Palmer CS, Healy KE, Desai K, Amsterdam J. Complementary and alternative medicine use among cancer survivors: A population-based study. J Cancer Surviv 2011;5:8-17.
Alvarez J, Meyer FL, Granoff DL, Lundy A. The effect of EEG biofeedback on reducing postcancer cognitive impairment. Integr Cancer Ther 2013;12:475-87.
Attia A, Rapp SR, Case LD, D′Agostino R, Lesser G, Naughton M, et al.
Phase II study of Ginkgo biloba
in irradiated brain tumor patients: Effect on cognitive function, quality of life, and mood. J Neurooncol 2012;109:357-63.
Barton DL, Burger K, Novotny PJ, Fitch TR, Kohli S, Soori G, et al.
The use of Ginkgo biloba
for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9. Support Care Cancer 2013;21:1185-92.
de Ruiter MA, Schouten-Van Meeteren AY, van Mourik R, Janssen TW, Greidanus JE, Oosterlaan J, et al.
Neurofeedback to improve neurocognitive functioning of children treated for a brain tumor: Design of a randomized controlled double-blind trial. BMC Cancer 2012;12:581.
Galantino ML, Greene L, Daniels L, Dooley B, Muscatello L, O′Donnell L. Longitudinal impact of yoga on chemotherapy-related cognitive impairment and quality of life in women with early stage breast cancer: A case series. Explore (NY) 2012;8:127-35.
Johnston MF, Hays RD, Subramanian SK, Elashoff RM, Axe EK, Li JJ, et al.
Patient education integrated with acupuncture for relief of cancer-related fatigue randomized controlled feasibility study. BMC Complement Altern Med 2011;11:49.
Oh B, Butow PN, Mullan BA, Clarke SJ, Beale PJ, Pavlakis N, et al.
Effect of medical Qigong on cognitive function, quality of life, and a biomarker of inflammation in cancer patients: A randomized controlled trial. Support Care Cancer 2012;20:1235-42.
Reid-Arndt SA, Matsuda S, Cox CR. Tai Chi effects on neuropsychological, emotional, and physical functioning following cancer treatment: A pilot study. Complement Ther Clin Pract 2012;18:26-30.
Speca M, Carlson LE, Goodey E, Angen M. A randomized, wait-list controlled clinical trial: The effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosom Med 2000;62:613-22.
Vadiraja HS, Rao MR, Nagarathna R, Nagendra HR, Rekha M, Vanitha N, et al.
Effects of yoga program on quality of life and affect in early breast cancer patients undergoing adjuvant radiotherapy: A randomized controlled trial. Complement Ther Med 2009;17:274-80.
Avisar A, River Y, Schiff E, Bar-Sela G, Steiner M, Ben-Arye E. Chemotherapy-related cognitive impairment: Does integrating complementary medicine have something to add? Review of the literature. Breast Cancer Res Treat 2012;136:1-7.
Biegler KA, Chaoul MA, Cohen L. Cancer, cognitive impairment, and meditation. Acta Oncol 2009;48:18-26.
Johnston MF, Yang C, Hui KK, Xiao B, Li XS, Rusiewicz A. Acupuncture for chemotherapy-associated cognitive dysfunction: A hypothesis-generating literature review to inform clinical advice. Integr Cancer Ther 2007;6:36-41.
van den Berg M, Visser A, Schoolmeesters A, Edelman P, van den Borne B. Evaluation of haptotherapy for patients with cancer treated with chemotherapy at a day clinic. Patient Educ Couns 2006;60:336-43.
van der Meij BS, Langius JA, Spreeuwenberg MD, Slootmaker SM, Paul MA, Smit EF, et al.
Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: An RCT. Eur J Clin Nutr 2012;66:399-404.
Chan AS, Cheung MC, Law SC, Chan JH. Phase II study of alpha-tocopherol in improving the cognitive function of patients with temporal lobe radionecrosis. Cancer Metastasis Rev 2004;100:398-404.
Cimprich B. Development of an intervention to restore attention in cancer patients. Cancer Nurs 1993;16:83-92.
Cimprich B, Ronis DL. An environmental intervention to restore attention in women with newly diagnosed breast cancer. Cancer Nurs 2003;26:284-92.
Hoffman CJ, Ersser SJ, Hopkinson JB, Nicholls PG, Harrington JE, Thomas PW. Effectiveness of mindfulness-based stress reduction in mood, breast- and endocrine-related quality of life, and well-being in stage 0 to III breast cancer: A randomized, controlled trial. J Clin Oncol 2012;30:1335-42.
Jatoi A, Kahanic SP, Frytak S, Schaefer P, Foote RL, Sloan J, et al.
Donepezil and vitamin E for preventing cognitive dysfunction in small cell lung cancer patients: Preliminary results and suggestions for future study designs. Support Care Cancer 2005;13:66-9.
Milbury K, Chaoul A, Biegler K, Wangyal T, Spelman A, Meyers CA, et al.
Tibetan sound meditation for cognitive dysfunction: Results of a randomized controlled pilot trial. Psychooncology 2013;22:2354-63.
Derry HM, Jaremka LM, Bennett JM, Peng J, Andridge R, Shapiro CL, et al.
Yoga and self-reported cognitive problems in breast cancer survivors: A randomized controlled trial. Psychooncology 2014;24:958-66.
Lesiuk T. The effect of mindfulness-based music therapy on attention and mood in women receiving adjuvant chemotherapy for breast cancer: A pilot study. Oncol rs Forum 2015;42:276-82.
Chan JS, Yan JH, Payne VG. The impact of obesity and exercise on cognitive aging. Front Aging Neurosci 2013;5:97.
Mazereeuw G, Lanctôt KL, Chau SA, Swardfager W, Herrmann N. Effects of ω-3 fatty acids on cognitive performance: A meta-analysis. Neurobiol Aging 2012;33:1482.e17-29.
Bishop SR, Lau M, Shapiro S, Carlson L, Anderson ND, Carmody J, et al.
Mindfulness: A proposed operational definition. Clin Psychol Sci Pract 2004;11:230-41.
Erickson KI, Voss MW, Prakash RS, Basak C, Szabo A, Chaddock L, et al.
Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci U S A 2011;108:3017-22.
Szuhany KL, Bugatti M, Otto MW. A meta-analytic review of the effects of exercise on brain-derived neurotrophic factor. J Psychiatr Res 2015;60:56-64.
Chaoul A, Milbury K, Sood AK, Prinsloo S, Cohen L. Mind-body practices in cancer care. Curr Oncol Rep 2014;16:417.
Kelley GA, Kelley KS. Meditative movement therapies and health-related quality-of-life in adults: A systematic review of meta-analyses. PLoS One 2015;10:e0129181.
Bosscher R, van Leeuwen A, Pluimers C. The clinical effectiveness of haptotherapy in routine practices. J Haptonomy Haptotherapy, published online 3/2/13. Available from: http://www.ijhh.org/userfiles/1362266844.pdf
. [Last accessed on 2013 Feb 03].
Lai JS, Butt Z, Wagner L, Sweet JJ, Beaumont JL, Vardy J, et al.
Evaluating the dimensionality of perceived cognitive function. J Pain Symptom Manage 2009;37:982-95.
Lai JS, Wagner LI, Jacobsen PB, Cella D. Self-reported cognitive concerns and abilities: Two sides of one coin? Psychooncology 2014;23:1133-41.
Saykin AJ, Wishart HA, Rabin LA, Santulli RB, Flashman LA, West JD, et al.
Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI. Neurology 2006;67:834-42.
Wefel JS, Vardy J, Ahles T, Schagen SB. International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol 2011;12:703-8.